Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Landsbankinn hf.: Covered bond exchange offering results
-
Urgently Completes Strategic Divestiture of The Floow in Support of Core Business Focus
-
Canacol Energy Ltd. Announces Revised 2024 Capital Program, Comments on 2024 Guidance and Provides Drilling Update
-
Nokia introduces Private Wireless Sustainability Calculator to help Enterprises reduce environmental footprint and improve worker safety
-
Kaiterra Unveils Sensedge Go, a Revolutionary Wireless Air Quality Monitor with the Longest Battery Life on the Market
-
Harbour Investment Partners Introduces Tax-Efficient Investment Strategies for High Net Worth Individuals
-
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
-
Open letter from the Chief Executive Officer.
-
CoinW Reaffirms Commitment to Top-Tier Security Following Industry Security Incident
-
Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”
-
Global Engine Group Holding Limited Announces Pricing of $8 Million Initial Public Offering
-
Nano Dimension and HENSOLDT AG Announce: Expanding Investment in their Joint Venture – J.A.M.E.S – For Advancement of 3D Printed Electronics Industry
-
Dr. Carlo Papa Appointed to Board of Directors of Odysight.ai
-
How to write the perfect AI prompt: iStock’s 10 step guide to transform ideas into stunning images
-
Forge Battery Selected for $100M Award Negotiation with U.S. Department of Energy to Expand Production Capacity of North Carolina Lithium-Ion Battery Gigafactory
-
Harbour Investment Partners Introduces Bespoke Wealth Management Solutions for Affluent Clients
-
Árshlutareikningur Hafnarfjarðarbæjar 30.06.2024 - fréttatilkynning leiðrétting (árshlutareikning vantaði í fyrri tilkynningu)
-
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
-
Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
-
Alaska Energy Metals Completes Helicopter-Borne VTEM Max Geophysical Survey and Soil Geochemical Survey at the Angliers - Belleterre Project, Quebec, Canada
-
Avante to Participate at the GSX 2024 Conference
-
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
-
Solid Power Selected by U.S. Department of Energy for Up to $50 Million Award Negotiation for Continuous Production of Sulfide-based Solid Electrolyte Materials for Advanced All-Solid-State Batteries
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
CALB Battery Expert -- "Zhijiu" new energy storage products shine at the RE+ Exhibition
-
CALB Battery Expert -- "Zhijiu" new energy storage products shine at the RE+ Exhibition
-
Rail Vision Announces its Participation in Global Events Lineup to Showcase its AI- Driven Railway Products
-
REPEAT - MEDIA ADVISORY: Charter Challenge on Bill 7 goes to court Monday
-
CleanCore Solutions, Inc. (ZONE) Reports 2024 Fiscal Year Financial Results and Provides Business Update
-
OTC Markets Group Welcomes Silver Crown Royalties Inc. to OTCQX
-
Algorhythm Holdings to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024 on September 24 and 25, 2024
-
Alamos Gold Helps to Create Inaugural Research Chair to Better Detect and Treat Gastrointestinal Cancers
-
Invesco Ltd: Form 8.3 - REA Group Ltd; Public dealing disclosure
-
VOYAH Courage Global Edition Debuts at Turin Motor Show, Showcasing the Excellence of Chinese Manufacturing
-
Invesco Ltd: Form 8.3 - Rightmove PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Nova Minerals Limited Provides an Update on the RPM Feasibility Study and Variation to the Nebari Convertible Facility
-
Nova Minerals Limited Publicly Files a Registration Statement With the SEC
-
FTAI Infrastructure Inc. Announces Timing of Third Quarter 2024 Earnings and Conference Call
-
U.S. Department of Energy Selects Standard Lithium and Equinor for Award Negotiation of Up to $225 Million for South West Arkansas Project
-
Form 8.3 - AXA INVESTMENT MANAGERS: REA Group Ltd
-
Sono Group N.V. Secures Funding, Reinforcing Its Financial Position
-
Form 8.3 - AXA INVESTMENT MANAGERS: Segro plc
-
Net Asset Value(s)
-
Innofactor Plc: Managers’ Transactions – Sami Ensio
-
Man Group PLC : Form 8.3 - Darktrace plc
-
Man Group PLC : Form 8.3 - Smith (DS) plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
Man Group PLC : Form 8.3 - AngloGold Ashanti plc
-
Press Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study
